The degree of illness was a surprise! Even the "M
Post# of 148175
If these patients weren't ever hospitalized, if they weren't in the hospital to begin with, I guess we can't say that Leronlimab sent them out the door faster than the placebo patients. How disappointing! That was the only metric Remdisavir seemed to improve!
Did none of the placebo group proceed to getting hospitalized and ending up in the severe/critical category? That is what I was hoping Leronlimab could demonstrate that it could prevent, extremely valuable!
I am underwhelmed!